Structured Follow-Up Reduces Heart Disease Readmissions and Improves Adherence

Bridging the Post-Discharge Gap in Coronary Management

The transition from acute hospital care to home management represents a period of significant vulnerability for patients with coronary heart disease, often marked by declining medication adherence and rising psychological distress. While patient-centered medical home models and coordinated primary care teams have shown potential in improving chronic disease outcomes and reducing hospital admissions, their implementation remains inconsistent [1, 2]. Current European and American guidelines emphasize the necessity of long-term risk factor modification, yet achieving sustained behavioral changes in diet and smoking cessation through standard nurse-led clinics has proven challenging [3, 4, 5]. Furthermore, the high prevalence of major adverse cardiovascular events following initial interventions underscores a critical need for more robust secondary prevention strategies [6]. A new study now evaluates a structured continuity of care protocol to determine if standardized post-discharge support can effectively mitigate these risks.

Evaluating Structured Post-Discharge Support

Coronary heart disease remains a leading cause of morbidity, requiring rigorous secondary prevention to prevent disease recurrence and maintain vascular stability. To address the frequent decline in treatment compliance following hospitalization, researchers evaluated the impact of a structured continuity of care model on 320 patients discharged between January 2021 and June 2023. The study utilized 1:1 propensity score matching (a statistical technique that pairs patients with similar baseline characteristics to mimic the balance of a randomized controlled trial and reduce the influence of confounding variables). This process resulted in a final analytical sample of 128 patients per group (256 total). By balancing variables such as age, comorbidities, and baseline health status, the authors were able to isolate the specific effects of the intervention on long-term recovery and clinical stability, comparing those receiving structured longitudinal support against a cohort receiving conventional follow-up protocols.

Quantifying Improvements in Medication Adherence

The primary outcome focused on treatment consistency at six months post-discharge, measured by the Medication Possession Ratio (MPR). The MPR is a validated clinical metric calculated by dividing the number of days a patient has a supply of medication by the total number of days in the study period, providing a reliable proxy for actual drug intake. In the intervention group, the mean MPR was significantly higher at 86.3 ± 9.7%, compared to 67.5 ± 11.3% in the conventional care group, yielding a mean difference of 18.8% (95% CI: 16.1% to 21.5%). This suggests that structured follow-up effectively bridges the gap between acute stabilization and long-term maintenance therapy. Furthermore, the study assessed the proportion of patients achieving good adherence (defined as an MPR of 80% or higher). The intervention group demonstrated a good adherence rate of 82.0%, whereas only 53.9% of the conventional care group met this threshold, representing a relative risk of 1.52 (95% CI: 1.31 to 1.77). For the practicing clinician, these data indicate that patients in the structured program were 52% more likely to maintain the therapeutic levels of medication necessary to prevent secondary cardiac events.

Impact on Psychological Distress and Readmission Risk

Psychological morbidity is a known driver of poor outcomes in coronary heart disease, as anxiety and depression often interfere with a patient's ability to engage in self-care. To quantify this, the researchers used the Hospital Anxiety and Depression Scale (HADS), a fourteen-item tool designed to screen for emotional distress in non-psychiatric clinical settings. The findings revealed that HADS anxiety scores were notably lower in the intervention group at 6.1 ± 2.2, compared to 9.0 ± 2.6 in the conventional care group. Similarly, HADS depression scores were 5.7 ± 2.4 in the intervention group versus 8.6 ± 2.8 in the control cohort, suggesting that structured support may mitigate the emotional burden of recovering from a major cardiovascular event. Most critically, these behavioral and psychological improvements correlated with a sharp reduction in clinical instability. The 6-month cardiovascular readmission rate was 5.5% in the intervention group compared to 16.4% in the conventional care group, a nearly three-fold reduction in the risk of re-hospitalization. This effect was statistically robust, with a relative risk for cardiovascular readmission of 0.33 (95% CI: 0.15 to 0.72), demonstrating that structured continuity of care provides a significant protective effect against acute recurrence.

Clinical Implications for Secondary Prevention

The findings suggest that a transition from episodic follow-up to a standardized, longitudinal model of care can profoundly alter the post-discharge trajectory for patients with coronary heart disease. By achieving a 6-month cardiovascular readmission rate of 5.5% and a mean Medication Possession Ratio of 86.3 ± 9.7%, the structured intervention addressed both the physiological and behavioral barriers to recovery. The reduction in psychological distress, evidenced by lower Hospital Anxiety and Depression Scale scores for anxiety (6.1 ± 2.2) and depression (5.7 ± 2.4), highlights the importance of addressing the patient's emotional state to ensure long-term stability. While these results from 256 matched patients provide a strong signal of efficacy, the authors emphasize the need for multicenter validation to confirm these findings across more diverse healthcare systems and socioeconomic backgrounds. For now, the data support the gradual incorporation of structured continuity of care into routine cardiovascular rehabilitation to reduce the risk of secondary events and improve the overall quality of life for post-discharge patients.

References

1. John JR, Jani H, Peters K, Agho K, Tannous K. The Effectiveness of Patient-Centred Medical Home-Based Models of Care versus Standard Primary Care in Chronic Disease Management: A Systematic Review and Meta-Analysis of Randomised and Non-Randomised Controlled Trials. International Journal of Environmental Research and Public Health. 2020. doi:10.3390/ijerph17186886

2. Baker R, Freeman GK, Haggerty JL, Bankart MJ, Nockels KH. Primary medical care continuity and patient mortality: a systematic review.. The British journal of general practice : the journal of the Royal College of General Practitioners. 2020. doi:10.3399/bjgp20X712289

3. Perk J, Backer GD, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal. 2012. doi:10.1093/eurheartj/ehs092

4. Schadewaldt V, Schultz T. A systematic review on the effectiveness of nurse-led cardiac clinics for adult patients with coronary heart disease.. JBI library of systematic reviews. 2010. doi:10.11124/01938924-201008020-00001

5. Schadewaldt V, Schultz T. Nurse-led clinics as an effective service for cardiac patients: results from a systematic review.. International journal of evidence-based healthcare. 2011. doi:10.1111/j.1744-1609.2011.00217.x

6. Obi CF, Okeke CC, Onyema AU, et al. Percutaneous Coronary Intervention in Africa: A Systematic Review of Associated Outcomes.. Cureus. 2025. doi:10.7759/cureus.88488